CD4+ T Cells in High-Risk MDS Patients Bear an Aberrant STAT Signaling BiosignatureEleftheria Lamprianidou, Ιoannis Kotsianidis, Sotirios G. Papageorgiou et al.|Blood|2014Cited by 1
Data from The Stat3/5 Signaling Biosignature in Hematopoietic Stem/Progenitor Cells Predicts Response and Outcome in Myelodysplastic Syndrome Patients Treated with AzacitidineParaskevi Miltiades, Ιoannis Kotsianidis, Eleftheria Lamprianidou et al.|Unknown|2023Cited by 0